HEADER HYDROLASE/PROTEIN BINDING 24-NOV-10 2XZD TITLE CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: P17 SUBUNIT, RESIDUES 29-175; COMPND 5 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32 PROTEIN COMPND 6 YAM, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 7 EC: 3.4.22.56; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CASPASE-3; COMPND 12 CHAIN: B, D; COMPND 13 FRAGMENT: P12 SUBUNIT, RESIDUES 176-277; COMPND 14 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32 PROTEIN COMPND 15 YAM, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 16 EC: 3.4.22.56; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 3; COMPND 19 MOLECULE: DARPIN-3.4; COMPND 20 CHAIN: G, H; COMPND 21 ENGINEERED: YES; COMPND 22 OTHER_DETAILS: IN-VITRO EVOLVED SEQUENCE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PET28; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 21 ORGANISM_TAXID: 32630; SOURCE 22 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 24 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 25 EXPRESSION_SYSTEM_VARIANT: XL1BLUE; SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_VECTOR: PQE30 KEYWDS HYDROLASE-PROTEIN BINDING COMPLEX, DE NOVO PROTEIN, APOPTOSIS, KEYWDS 2 ANKYRIN REPEAT PROTEIN, RIBOSOME DISPLAY EXPDTA X-RAY DIFFRACTION AUTHOR J.BARANDUN,T.SCHROEDER,P.MITTL,M.G.GRUTTER REVDAT 4 20-DEC-23 2XZD 1 REMARK LINK REVDAT 3 20-FEB-13 2XZD 1 COMPND JRNL REVDAT 2 30-JAN-13 2XZD 1 JRNL REVDAT 1 14-DEC-11 2XZD 0 JRNL AUTH T.SCHROEDER,J.BARANDUN,A.FLUTSCH,C.BRIAND,P.MITTL, JRNL AUTH 2 M.G.GRUTTER JRNL TITL SPECIFIC INHIBITION OF CASPASE-3 BY A COMPETITIVE DARPIN: JRNL TITL 2 MOLECULAR MIMICRY BETWEEN NATIVE AND DESIGNED INHIBITORS. JRNL REF STRUCTURE V. 21 277 2013 JRNL REFN ISSN 0969-2126 JRNL PMID 23333429 JRNL DOI 10.1016/J.STR.2012.12.011 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 59961 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3211 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4393 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.3450 REMARK 3 BIN FREE R VALUE SET COUNT : 226 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5606 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 317 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.53000 REMARK 3 B22 (A**2) : 0.53000 REMARK 3 B33 (A**2) : -0.79000 REMARK 3 B12 (A**2) : 0.26000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.161 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.147 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.119 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.660 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5748 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7752 ; 1.192 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 711 ; 8.254 ; 5.056 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 277 ;33.806 ;24.296 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1022 ;13.918 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;17.665 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 860 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4302 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3513 ; 0.540 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5642 ; 1.060 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2235 ; 1.796 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2108 ; 2.965 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 34 A 174 REMARK 3 ORIGIN FOR THE GROUP (A): 42.0754 10.3826 10.5587 REMARK 3 T TENSOR REMARK 3 T11: 0.4199 T22: 0.0861 REMARK 3 T33: 0.1032 T12: 0.0923 REMARK 3 T13: 0.0167 T23: 0.0194 REMARK 3 L TENSOR REMARK 3 L11: 1.3022 L22: 3.4928 REMARK 3 L33: 2.0742 L12: -0.3346 REMARK 3 L13: 0.1232 L23: 0.6870 REMARK 3 S TENSOR REMARK 3 S11: 0.0122 S12: 0.2589 S13: 0.1049 REMARK 3 S21: -0.7043 S22: -0.0481 S23: -0.1988 REMARK 3 S31: -0.4166 S32: -0.0005 S33: 0.0359 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 184 B 277 REMARK 3 ORIGIN FOR THE GROUP (A): 35.8737 -1.6259 13.1795 REMARK 3 T TENSOR REMARK 3 T11: 0.2431 T22: 0.1141 REMARK 3 T33: 0.1332 T12: 0.0709 REMARK 3 T13: -0.0347 T23: -0.0357 REMARK 3 L TENSOR REMARK 3 L11: 1.3137 L22: 2.6846 REMARK 3 L33: 2.3517 L12: -0.5695 REMARK 3 L13: -0.4658 L23: 1.1823 REMARK 3 S TENSOR REMARK 3 S11: -0.0286 S12: 0.2224 S13: -0.1664 REMARK 3 S21: -0.3396 S22: -0.0677 S23: 0.1650 REMARK 3 S31: -0.1283 S32: -0.3430 S33: 0.0963 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 34 C 175 REMARK 3 ORIGIN FOR THE GROUP (A): 41.6805 -9.5836 36.2574 REMARK 3 T TENSOR REMARK 3 T11: 0.2200 T22: 0.0530 REMARK 3 T33: 0.1527 T12: 0.0696 REMARK 3 T13: 0.0382 T23: 0.0197 REMARK 3 L TENSOR REMARK 3 L11: 1.3643 L22: 2.2139 REMARK 3 L33: 2.4572 L12: -0.2527 REMARK 3 L13: 0.0706 L23: 0.1186 REMARK 3 S TENSOR REMARK 3 S11: -0.1345 S12: -0.1209 S13: -0.2440 REMARK 3 S21: 0.1680 S22: 0.1344 S23: 0.0045 REMARK 3 S31: 0.3662 S32: -0.1098 S33: 0.0001 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 185 D 277 REMARK 3 ORIGIN FOR THE GROUP (A): 35.4594 2.3045 33.5186 REMARK 3 T TENSOR REMARK 3 T11: 0.1764 T22: 0.0941 REMARK 3 T33: 0.1430 T12: 0.0995 REMARK 3 T13: 0.0264 T23: 0.0057 REMARK 3 L TENSOR REMARK 3 L11: 1.4395 L22: 2.5902 REMARK 3 L33: 2.8163 L12: 0.2576 REMARK 3 L13: 0.4621 L23: 1.0639 REMARK 3 S TENSOR REMARK 3 S11: -0.1195 S12: -0.1237 S13: -0.0050 REMARK 3 S21: 0.0547 S22: 0.0314 S23: 0.2076 REMARK 3 S31: -0.0356 S32: -0.3165 S33: 0.0882 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : G 13 G 131 REMARK 3 ORIGIN FOR THE GROUP (A): 61.1791 -15.1560 -6.4119 REMARK 3 T TENSOR REMARK 3 T11: 0.1975 T22: 0.1024 REMARK 3 T33: 0.1638 T12: 0.0192 REMARK 3 T13: 0.0763 T23: -0.0803 REMARK 3 L TENSOR REMARK 3 L11: 6.0931 L22: 5.0518 REMARK 3 L33: 11.8244 L12: -1.5527 REMARK 3 L13: -4.5885 L23: 5.8056 REMARK 3 S TENSOR REMARK 3 S11: 0.5919 S12: -0.2071 S13: 0.3380 REMARK 3 S21: -0.2096 S22: 0.1632 S23: -0.5457 REMARK 3 S31: -0.7164 S32: 0.5016 S33: -0.7551 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 13 H 132 REMARK 3 ORIGIN FOR THE GROUP (A): 60.6808 15.7576 52.6706 REMARK 3 T TENSOR REMARK 3 T11: 0.1743 T22: 0.2712 REMARK 3 T33: 0.0552 T12: 0.0656 REMARK 3 T13: -0.0617 T23: -0.0585 REMARK 3 L TENSOR REMARK 3 L11: 4.4972 L22: 2.5848 REMARK 3 L33: 7.8324 L12: 0.6344 REMARK 3 L13: 1.0825 L23: 3.0049 REMARK 3 S TENSOR REMARK 3 S11: 0.2493 S12: 0.0094 S13: -0.2082 REMARK 3 S21: 0.0012 S22: 0.1076 S23: -0.1706 REMARK 3 S31: -0.0451 S32: 1.0981 S33: -0.3569 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XZD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63172 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 49.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.920 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.03 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.920 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2DKO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, PH 7.3 (RT), 40 % 2 REMARK 280 -METHYL-2,4-PENTANEDIOL. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.53333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 129.06667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 129.06667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 64.53333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 27 REMARK 465 SER A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 ASP A 175 REMARK 465 SER B 176 REMARK 465 GLY B 177 REMARK 465 VAL B 178 REMARK 465 ASP B 179 REMARK 465 ASP B 180 REMARK 465 ASP B 181 REMARK 465 MET B 182 REMARK 465 ALA B 183 REMARK 465 ALA B 278 REMARK 465 LEU B 279 REMARK 465 GLU B 280 REMARK 465 VAL B 281 REMARK 465 LEU B 282 REMARK 465 PHE B 283 REMARK 465 GLN B 284 REMARK 465 GLY B 285 REMARK 465 PRO B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 465 HIS B 290 REMARK 465 HIS B 291 REMARK 465 HIS B 292 REMARK 465 HIS B 293 REMARK 465 MET C 27 REMARK 465 SER C 28 REMARK 465 SER C 29 REMARK 465 GLY C 30 REMARK 465 ILE C 31 REMARK 465 SER C 32 REMARK 465 LEU C 33 REMARK 465 SER D 176 REMARK 465 GLY D 177 REMARK 465 VAL D 178 REMARK 465 ASP D 179 REMARK 465 ASP D 180 REMARK 465 ASP D 181 REMARK 465 MET D 182 REMARK 465 ALA D 183 REMARK 465 CYS D 184 REMARK 465 ALA D 278 REMARK 465 LEU D 279 REMARK 465 GLU D 280 REMARK 465 VAL D 281 REMARK 465 LEU D 282 REMARK 465 PHE D 283 REMARK 465 GLN D 284 REMARK 465 GLY D 285 REMARK 465 PRO D 286 REMARK 465 HIS D 287 REMARK 465 HIS D 288 REMARK 465 HIS D 289 REMARK 465 HIS D 290 REMARK 465 HIS D 291 REMARK 465 HIS D 292 REMARK 465 HIS D 293 REMARK 465 MET G 1 REMARK 465 ARG G 2 REMARK 465 GLY G 3 REMARK 465 SER G 4 REMARK 465 HIS G 5 REMARK 465 HIS G 6 REMARK 465 HIS G 7 REMARK 465 HIS G 8 REMARK 465 HIS G 9 REMARK 465 HIS G 10 REMARK 465 GLY G 11 REMARK 465 SER G 12 REMARK 465 LEU G 132 REMARK 465 GLN G 133 REMARK 465 LYS G 134 REMARK 465 LEU G 135 REMARK 465 ASN G 136 REMARK 465 MET H 1 REMARK 465 ARG H 2 REMARK 465 GLY H 3 REMARK 465 SER H 4 REMARK 465 HIS H 5 REMARK 465 HIS H 6 REMARK 465 HIS H 7 REMARK 465 HIS H 8 REMARK 465 HIS H 9 REMARK 465 HIS H 10 REMARK 465 GLY H 11 REMARK 465 SER H 12 REMARK 465 GLN H 133 REMARK 465 LYS H 134 REMARK 465 LEU H 135 REMARK 465 ASN H 136 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A 1175 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD B 1278 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD C 1176 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD C 1177 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RHK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH A PHENYL-PROPYL- REMARK 900 KETONE INHIBITOR REMARK 900 RELATED ID: 1RHQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH REMARK 900 ABROMOMETHOXYPHENYL INHIBITOR REMARK 900 RELATED ID: 2DKO RELATED DB: PDB REMARK 900 EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BYHIGH REMARK 900 RESOLUTION X-RAY STRUCTURE ANALYSIS REMARK 900 RELATED ID: 2XYP RELATED DB: PDB REMARK 900 CASPASE-3:CAS26049945 REMARK 900 RELATED ID: 2CJY RELATED DB: PDB REMARK 900 EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH REMARK 900 RESOLUTION X-RAY STRUCTURE ANALYSIS REMARK 900 RELATED ID: 2J31 RELATED DB: PDB REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND REMARK 900 ACTIVITY OF(PRO)CASPASE -3 REMARK 900 RELATED ID: 2XYH RELATED DB: PDB REMARK 900 CASPASE-3:CAS60254719 REMARK 900 RELATED ID: 2CJX RELATED DB: PDB REMARK 900 EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH REMARK 900 RESOLUTION X-RAY STRUCTURE ANALYSIS REMARK 900 RELATED ID: 1RE1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACIDALDEHYDE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2XYG RELATED DB: PDB REMARK 900 CASPASE-3:CAS329306 REMARK 900 RELATED ID: 2C1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL REMARK 900 ACCEPTOR INHIBITORS. REMARK 900 RELATED ID: 2CNO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 1GFW RELATED DB: PDB REMARK 900 THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN ORCPP32)IN REMARK 900 COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR. REMARK 900 RELATED ID: 1QX3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OFUNLIGANDED HUMAN REMARK 900 CASPASE-3 REMARK 900 RELATED ID: 1RHM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH ANICOTINIC ACID REMARK 900 ALDEHYDE INHIBITOR REMARK 900 RELATED ID: 1NME RELATED DB: PDB REMARK 900 STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE REMARK 900 RELATED ID: 2J33 RELATED DB: PDB REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND REMARK 900 ACTIVITY OF (PRO) CASPASE-3 REMARK 900 RELATED ID: 1RHR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH ACINNAMIC ACID REMARK 900 METHYL ESTER INHIBITOR REMARK 900 RELATED ID: 1NMS RELATED DB: PDB REMARK 900 CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR REMARK 900 RELATED ID: 1NMQ RELATED DB: PDB REMARK 900 EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS REMARK 900 RELATED ID: 1RHJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH APRYAZINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2CNN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2C2K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL REMARK 900 ACCEPTOR INHIBITORS. REMARK 900 RELATED ID: 2CNL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2C2M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL REMARK 900 ACCEPTOR INHIBITORS. REMARK 900 RELATED ID: 1CP3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE REMARK 900 INHIBITOR ACE-DVAD- FMC REMARK 900 RELATED ID: 2CNK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2J30 RELATED DB: PDB REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND REMARK 900 ACTIVITY OF (PRO) CASPASE-3 REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE REMARK 900 ALDEHYDE INHIBITOR AC -DEVD-CHO REMARK 900 RELATED ID: 2CDR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2J32 RELATED DB: PDB REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND REMARK 900 ACTIVITY OF(PRO)CASPASE -3 REMARK 900 RELATED ID: 1I3O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP- BIR2 AND CASPASE 3 REMARK 900 RELATED ID: 1RHU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH A 5,6, REMARK 900 7TRICYCLIC PEPTIDOMIMETIC INHIBITOR REMARK 900 RELATED ID: 2C2O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL REMARK 900 ACCEPTOR INHIBITORS. REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHAIN A AND C, ASP 28 TO SER MUTATIONS FROM CLONING STRATEGY. DBREF 2XZD A 27 175 UNP P42574 CASP3_HUMAN 27 175 DBREF 2XZD B 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 2XZD C 27 175 UNP P42574 CASP3_HUMAN 27 175 DBREF 2XZD D 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 2XZD G 1 136 PDB 2XZD 2XZD 1 136 DBREF 2XZD H 1 136 PDB 2XZD 2XZD 1 136 SEQADV 2XZD SER A 28 UNP P42574 ASP 28 ENGINEERED MUTATION SEQADV 2XZD ALA B 278 UNP P42574 EXPRESSION TAG SEQADV 2XZD LEU B 279 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLU B 280 UNP P42574 EXPRESSION TAG SEQADV 2XZD VAL B 281 UNP P42574 EXPRESSION TAG SEQADV 2XZD LEU B 282 UNP P42574 EXPRESSION TAG SEQADV 2XZD PHE B 283 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLN B 284 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLY B 285 UNP P42574 EXPRESSION TAG SEQADV 2XZD PRO B 286 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 287 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 288 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 289 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 290 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 291 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 292 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS B 293 UNP P42574 EXPRESSION TAG SEQADV 2XZD SER C 28 UNP P42574 ASP 28 ENGINEERED MUTATION SEQADV 2XZD ALA D 278 UNP P42574 EXPRESSION TAG SEQADV 2XZD LEU D 279 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLU D 280 UNP P42574 EXPRESSION TAG SEQADV 2XZD VAL D 281 UNP P42574 EXPRESSION TAG SEQADV 2XZD LEU D 282 UNP P42574 EXPRESSION TAG SEQADV 2XZD PHE D 283 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLN D 284 UNP P42574 EXPRESSION TAG SEQADV 2XZD GLY D 285 UNP P42574 EXPRESSION TAG SEQADV 2XZD PRO D 286 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 287 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 288 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 289 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 290 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 291 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 292 UNP P42574 EXPRESSION TAG SEQADV 2XZD HIS D 293 UNP P42574 EXPRESSION TAG SEQRES 1 A 149 MET SER SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 2 A 149 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 3 A 149 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 4 A 149 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 5 A 149 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 6 A 149 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 7 A 149 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 8 A 149 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 9 A 149 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 10 A 149 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 11 A 149 LEU PHE ILE ILE GLN ALA CSO ARG GLY THR GLU LEU ASP SEQRES 12 A 149 CYS GLY ILE GLU THR ASP SEQRES 1 B 118 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 118 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 118 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 118 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 118 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 118 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 118 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 118 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS ALA LEU SEQRES 9 B 118 GLU VAL LEU PHE GLN GLY PRO HIS HIS HIS HIS HIS HIS SEQRES 10 B 118 HIS SEQRES 1 C 149 MET SER SER GLY ILE SER LEU ASP ASN SER TYR LYS MET SEQRES 2 C 149 ASP TYR PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN SEQRES 3 C 149 LYS ASN PHE HIS LYS SER THR GLY MET THR SER ARG SER SEQRES 4 C 149 GLY THR ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE SEQRES 5 C 149 ARG ASN LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU SEQRES 6 C 149 THR ARG GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER SEQRES 7 C 149 LYS GLU ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL SEQRES 8 C 149 LEU LEU SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR SEQRES 9 C 149 ASN GLY PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE SEQRES 10 C 149 ARG GLY ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS SEQRES 11 C 149 LEU PHE ILE ILE GLN ALA CSO ARG GLY THR GLU LEU ASP SEQRES 12 C 149 CYS GLY ILE GLU THR ASP SEQRES 1 D 118 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 D 118 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 D 118 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 D 118 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 D 118 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 D 118 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 D 118 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 D 118 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS ALA LEU SEQRES 9 D 118 GLU VAL LEU PHE GLN GLY PRO HIS HIS HIS HIS HIS HIS SEQRES 10 D 118 HIS SEQRES 1 G 136 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ASP SEQRES 2 G 136 LEU GLY LYS LYS LEU LEU GLU ALA THR ARG ALA GLY GLN SEQRES 3 G 136 ASP ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA ASP SEQRES 4 G 136 VAL ASN ALA MET ASP ASP ALA GLY VAL THR PRO LEU HIS SEQRES 5 G 136 LEU ALA ALA LYS ARG GLY HIS LEU GLU ILE VAL GLU VAL SEQRES 6 G 136 LEU LEU LYS HIS GLY ALA ASP VAL ASN ALA SER ASP ILE SEQRES 7 G 136 TRP GLY ARG THR PRO LEU HIS LEU ALA ALA THR VAL GLY SEQRES 8 G 136 HIS LEU GLU ILE VAL GLU VAL LEU LEU GLU TYR GLY ALA SEQRES 9 G 136 ASP VAL ASN ALA GLN ASP LYS PHE GLY LYS THR ALA PHE SEQRES 10 G 136 ASP ILE SER ILE ASP ASN GLY ASN GLU ASP LEU ALA GLU SEQRES 11 G 136 ILE LEU GLN LYS LEU ASN SEQRES 1 H 136 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ASP SEQRES 2 H 136 LEU GLY LYS LYS LEU LEU GLU ALA THR ARG ALA GLY GLN SEQRES 3 H 136 ASP ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA ASP SEQRES 4 H 136 VAL ASN ALA MET ASP ASP ALA GLY VAL THR PRO LEU HIS SEQRES 5 H 136 LEU ALA ALA LYS ARG GLY HIS LEU GLU ILE VAL GLU VAL SEQRES 6 H 136 LEU LEU LYS HIS GLY ALA ASP VAL ASN ALA SER ASP ILE SEQRES 7 H 136 TRP GLY ARG THR PRO LEU HIS LEU ALA ALA THR VAL GLY SEQRES 8 H 136 HIS LEU GLU ILE VAL GLU VAL LEU LEU GLU TYR GLY ALA SEQRES 9 H 136 ASP VAL ASN ALA GLN ASP LYS PHE GLY LYS THR ALA PHE SEQRES 10 H 136 ASP ILE SER ILE ASP ASN GLY ASN GLU ASP LEU ALA GLU SEQRES 11 H 136 ILE LEU GLN LYS LEU ASN MODRES 2XZD CSO A 163 CYS S-HYDROXYCYSTEINE MODRES 2XZD CSO C 163 CYS S-HYDROXYCYSTEINE HET CSO A 163 7 HET CSO C 163 7 HET MRD A1175 8 HET MPD B1278 8 HET MRD C1176 8 HET MRD C1177 8 HETNAM CSO S-HYDROXYCYSTEINE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 7 MRD 3(C6 H14 O2) FORMUL 8 MPD C6 H14 O2 FORMUL 11 HOH *317(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 LYS A 105 1 14 HELIX 4 4 LEU A 136 PHE A 142 1 7 HELIX 5 5 CYS A 148 THR A 152 5 5 HELIX 6 6 TRP B 214 ALA B 227 1 14 HELIX 7 7 GLU B 231 PHE B 247 1 17 HELIX 8 8 ASP B 253 HIS B 257 5 5 HELIX 9 9 HIS C 56 GLY C 60 5 5 HELIX 10 10 GLY C 66 LEU C 81 1 16 HELIX 11 11 THR C 92 LYS C 105 1 14 HELIX 12 12 LEU C 136 PHE C 142 1 7 HELIX 13 13 CYS C 148 THR C 152 5 5 HELIX 14 14 TRP D 214 ALA D 227 1 14 HELIX 15 15 GLU D 231 PHE D 247 1 17 HELIX 16 16 ASP D 253 HIS D 257 5 5 HELIX 17 17 ASP G 13 ALA G 24 1 12 HELIX 18 18 GLN G 26 ASN G 36 1 11 HELIX 19 19 THR G 49 GLY G 58 1 10 HELIX 20 20 HIS G 59 HIS G 69 1 11 HELIX 21 21 THR G 82 GLY G 91 1 10 HELIX 22 22 HIS G 92 TYR G 102 1 11 HELIX 23 23 THR G 115 ASN G 123 1 9 HELIX 24 24 ASN G 125 ALA G 129 5 5 HELIX 25 25 ASP H 13 ALA H 24 1 12 HELIX 26 26 GLN H 26 ASN H 36 1 11 HELIX 27 27 THR H 49 GLY H 58 1 10 HELIX 28 28 HIS H 59 HIS H 69 1 11 HELIX 29 29 THR H 82 GLY H 91 1 10 HELIX 30 30 HIS H 92 TYR H 102 1 11 HELIX 31 31 THR H 115 ASN H 123 1 9 SHEET 1 AA12 GLU A 84 ASN A 89 0 SHEET 2 AA12 GLU A 43 ASN A 51 1 O GLY A 45 N GLU A 84 SHEET 3 AA12 ARG A 111 LEU A 119 1 N SER A 112 O GLU A 43 SHEET 4 AA12 LYS A 156 GLN A 161 1 O LEU A 157 N CYS A 116 SHEET 5 AA12 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 AA12 CYS B 264 SER B 267 -1 O CYS B 264 N TYR B 197 SHEET 7 AA12 CYS D 264 SER D 267 -1 O ILE D 265 N SER B 267 SHEET 8 AA12 PHE D 193 TYR D 197 -1 O TYR D 195 N VAL D 266 SHEET 9 AA12 LYS C 156 GLN C 161 1 O LYS C 156 N LEU D 194 SHEET 10 AA12 ARG C 111 LEU C 119 1 O PHE C 114 N LEU C 157 SHEET 11 AA12 GLU C 43 ASN C 51 1 O GLU C 43 N SER C 112 SHEET 12 AA12 GLU C 84 ASN C 89 1 O GLU C 84 N CYS C 47 SHEET 1 AB 3 GLY A 122 GLU A 123 0 SHEET 2 AB 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 AB 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 AC 2 ILE A 172 GLU A 173 0 SHEET 2 AC 2 LYS D 186 ILE D 187 -1 O ILE D 187 N ILE A 172 SHEET 1 BA 2 LYS B 186 ILE B 187 0 SHEET 2 BA 2 ILE C 172 GLU C 173 -1 O ILE C 172 N ILE B 187 SHEET 1 BB 2 ARG B 207 ASN B 208 0 SHEET 2 BB 2 GLY B 212 SER B 213 -1 O GLY B 212 N ASN B 208 SHEET 1 CA 3 GLY C 122 GLU C 123 0 SHEET 2 CA 3 ILE C 126 GLY C 129 -1 O ILE C 126 N GLU C 123 SHEET 3 CA 3 GLY C 132 ASP C 135 -1 O GLY C 132 N GLY C 129 SHEET 1 DA 2 ARG D 207 ASN D 208 0 SHEET 2 DA 2 GLY D 212 SER D 213 -1 O GLY D 212 N ASN D 208 LINK C ALA A 162 N CSO A 163 1555 1555 1.32 LINK C CSO A 163 N ARG A 164 1555 1555 1.32 LINK C ALA C 162 N CSO C 163 1555 1555 1.33 LINK C CSO C 163 N ARG C 164 1555 1555 1.33 SITE 1 AC1 6 ASN A 51 ASP A 68 ALA A 71 ASN A 87 SITE 2 AC1 6 ASN A 89 GLU H 94 SITE 1 AC2 4 SER A 65 ARG B 207 SER B 209 ILE G 78 SITE 1 AC3 2 ASN C 87 ASN C 89 SITE 1 AC4 4 ASP A 107 ASN C 89 ASP C 90 GLU C 95 CRYST1 98.000 98.000 193.600 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010204 0.005891 0.000000 0.00000 SCALE2 0.000000 0.011783 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005165 0.00000